Literature DB >> 7979721

Pulmonary resection for metastatic breast cancer.

M L McDonald1, C Deschamps, D M Ilstrup, M S Allen, V F Trastek, P C Pairolero.   

Abstract

Between 1982 and 1992, 60 consecutive female patients underwent pulmonary resection for metastatic breast carcinoma. Median age was 58 years (range, 21 to 81 years). The median tumor-free interval after primary breast cancer operation was 2.2 years (range, 7 days to 20.6 years). Thirty-one patients (51.6%) had solitary pulmonary metastases. Forty patients (66.7%) had complete pulmonary resection, which consisted of wedge excision in 33, lobectomy in 6, and pneumonectomy in 1. The remaining 20 patients had incomplete resection, which consisted of wedge excision in all. Altogether, 8 patients (13.3%) had development of postoperative complications, which included pneumothorax, prolonged air leak, pulmonary embolism, retained secretions requiring bronchoscopy, atrial fibrillation, and chest tube site infection. There was one operative death (1.7%). Follow-up was complete in all patients and ranged from 23 days to 10.7 years (median, 3.5 years). Recurrence developed in 32 of the 39 survivors (82.1%) who had complete resection. Median disease-free interval after lung resection was 1.6 years (range, 23 days to 9.3 years). Overall 5-year survival was 37.8% (95% confidence interval, 25.1% to 50.5%). The 40 patients who had complete resection had a 5-year survival of 35.6% (95% confidence interval, 20.4% to 50.8%) as compared with 42.1% (95% confidence interval, 19.0% to 65.3%) for the 20 patients with incomplete resection (p = not significant). Although pulmonary resection is safe, we could not demonstrate improved survival after complete pulmonary resection of metastatic breast carcinoma in this highly selected group of patients.

Entities:  

Mesh:

Year:  1994        PMID: 7979721     DOI: 10.1016/0003-4975(94)91639-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  16 in total

Review 1.  Improvement of survival and prospect of cure in patients with metastatic breast cancer.

Authors:  Yee Chung Cheng; Naoto T Ueno
Journal:  Breast Cancer       Date:  2011-05-13       Impact factor: 4.239

Review 2.  Oligometastatic Breast Cancer: Is This a Curable Entity? A Contemporary Review of the Literature.

Authors:  Igor Makhlin; Kevin Fox
Journal:  Curr Oncol Rep       Date:  2020-02-05       Impact factor: 5.075

3.  The evolution of the role of surgery in the management of breast cancer lung metastasis.

Authors:  Omar M Rashid; Kazuaki Takabe
Journal:  J Thorac Dis       Date:  2012-08       Impact factor: 2.895

Review 4.  Metastasectomy and surgical resection of the primary tumor in patients with stage IV breast cancer: time for a second look?

Authors:  Barbara A Pockaj; Nabil Wasif; Amylou C Dueck; Dennis A Wigle; Judy C Boughey; Amy C Degnim; Richard J Gray; Sarah A McLaughlin; Donald W Northfelt; Robert P Sticca; James W Jakub; Edith A Perez
Journal:  Ann Surg Oncol       Date:  2010-03-16       Impact factor: 5.344

5.  Prognostic factors for resection of isolated pulmonary metastases in breast cancer patients: a systematic review and meta-analysis.

Authors:  Jun Fan; Dali Chen; Heng Du; Cheng Shen; Guowei Che
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

Review 6.  Current status of pulmonary metastasectomy from primary epithelial tumors.

Authors:  Tokujiro Yano; Fumihiro Shoji; Yoshihiko Maehara
Journal:  Surg Today       Date:  2009-02-07       Impact factor: 2.549

Review 7.  Treatment Strategies for Oligometastatic Breast Cancer.

Authors:  Eric G Nesbit; Eric D Donnelly; Jonathan B Strauss
Journal:  Curr Treat Options Oncol       Date:  2021-08-23

Review 8.  International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?

Authors:  Olivia Pagani; Elzbieta Senkus; William Wood; Marco Colleoni; Tanja Cufer; Stella Kyriakides; Alberto Costa; Eric P Winer; Fatima Cardoso
Journal:  J Natl Cancer Inst       Date:  2010-03-10       Impact factor: 13.506

9.  Pulmonary resection and systemic lymph node dissection in a patient with breast cancer who had a 33-year disease-free interval.

Authors:  Degang Yin; Guofei Zhang; Lufeng Zhao; Ying Chai
Journal:  World J Surg Oncol       Date:  2015-04-16       Impact factor: 2.754

10.  Hormone receptor status may impact the survival benefit of surgery in stage iv breast cancer: a population-based study.

Authors:  Yinuo Tan; Xiaofen Li; Haiyan Chen; Yeting Hu; Mengjie Jiang; Jianfei Fu; Ying Yuan; Kefeng Ding
Journal:  Oncotarget       Date:  2016-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.